Vinay Prasad, CBER director (FDA via YouTube)
New CBER chief Prasad promises to 'rapidly' push even small advances for rare disease drugs
The FDA’s new head of biologics Vinay Prasad said he plans to “rapidly make available” even small advances in rare disease treatments, a sign of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
